BioGaia AB (FRA:BGLA)
€ 9.115 -0.035 (-0.38%) Market Cap: 931.59 Mil Enterprise Value: 835.03 Mil PE Ratio: 31.83 PB Ratio: 6.64 GF Score: 95/100

Q1 2022 Biogaia AB Interim Management Statement Call Transcript

May 06, 2022 / 07:30AM GMT
Release Date Price: €11.24 (-1.75%)
Operator

Ladies and gentlemen, welcome to the BioGaia Audio Cast and Teleconference Q1 2022. (Operator Instructions)

Today I am pleased to present CEO, Isabelle Ducellier; and CFO, Alexander Kotsinas. Dear speakers, please go ahead.

Isabelle Valerie Ghislaine Ducellier;publ;CEO;President
BioGaia AB

()-&

Thank you for the introduction, and good morning, everyone. I have to admit that I am particularly pleased with our quarter. We are over-performing on all important parameters, starting with one of the most important, the sales. We have a record revenue with SEK 284 million, which is a pretty strong increase of plus 41% versus last year first quarter. And for the one following us, you would probably remember that the first quarter last year was strong as well, but not that strong, but strong as well. And this is mainly driven by strong demand worldwide and especially the comeback of Europe.

On the operating profit, here as well pretty impressive increase with plus 48%. We are able to have our EBIT

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot